Follow-up of patients with early breast cancerHAYES, Daniel F.The New England journal of medicine. 2007, Vol 356, Num 24, pp 2505-2513, issn 0028-4793, 9 p.Article

Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer?HAYES, Daniel F; SMERAGE, Jeffrey.Clinical cancer research. 2008, Vol 14, Num 12, pp 3646-3650, issn 1078-0432, 5 p.Article

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancerYAMAUCHI, Hideko; STEARNS, Vered; HAYES, Daniel F et al.Journal of clinical oncology. 2001, Vol 19, Num 8, pp 2334-2356, issn 0732-183XArticle

Tumour marker development : Towards validation of clinically useful markersHAYES, Daniel F.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 5, pp 77-81, issn 1359-6349, 5 p.Conference Paper

Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent ReportingMCSHANE, Lisa M; HAYES, Daniel F.Journal of clinical oncology. 2012, Vol 30, Num 34, pp 4223-4232, issn 0732-183X, 10 p.Article

New prognostic factors for breast cancer recurrenceISAACS, Claudine; STEARNS, Vered; HAYES, Daniel F et al.Seminars in oncology. 2001, Vol 28, Num 1, pp 53-67, issn 0093-7754Article

CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer PatientsRAE, James M; DRURY, Suzy; HAYES, Daniel F et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 6, pp 452-460, issn 0027-8874, 9 p.Article

Biospecimen Reporting for Improved Study Quality (BRISQ)MOORE, Helen M; KELLY, Andrea B; POTAPOVA, Olga et al.Cancer cytopathology. 2011, Vol 119, Num 2, pp 92-101, issn 1934-662X, 10 p.Article

Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohortHENRY, N. Lynn; RAE, James M; HAYES, Daniel F et al.Breast cancer research and treatment. 2009, Vol 117, Num 3, pp 571-575, issn 0167-6806, 5 p.Article

Point-of-care biosensor systems for cancer diagnostics/prognosticsSOPER, Steven A; BROWN, Kathlynn; LARSON, Dale et al.Biosensors & bioelectronics. 2006, Vol 21, Num 10, pp 1932-1942, issn 0956-5663, 11 p.Article

A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in Women at high risk with biomarkers as surrogate endpoints for activitySTEARNS, Vered; GALLAGHER, Ann; TROCK, Bruce et al.Clinical cancer research. 2004, Vol 10, Num 24, pp 8332-8340, issn 1078-0432, 9 p.Article

A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancerSTEARNS, Vered; SINGH, Baljit; SLACK, Rebecca et al.Clinical cancer research. 2003, Vol 9, Num 1, pp 124-133, issn 1078-0432, 10 p.Article

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer : Cancer and leukemia Group B study 8662HAYES, Daniel F; YAMAUCHI, Hideko; NORTON, Larry et al.Clinical cancer research. 2001, Vol 7, Num 9, pp 2703-2711, issn 1078-0432Article

HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant TrastuzumabITHIMAKIN, Suthinee; DAY, Kathleen C; HALL, Christopher L et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 5, pp 1635-1645, issn 0008-5472, 11 p.Article

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast CancerLYNN HENRY, N; AZZOUZ, Faouzi; STEARNS, Vered et al.Journal of clinical oncology. 2012, Vol 30, Num 9, pp 936-942, issn 0732-183X, 7 p.Article

American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell TumorsGILLIGAN, Timothy D; SEIDENFELD, Jerome; BASCH, Ethan M et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3388-3404, issn 0732-183X, 17 p.Article

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerHAMMOND, M. Elizabeth H; HAYES, Daniel F; HICKS, David G et al.Journal of clinical oncology. 2010, Vol 28, Num 16, pp 2784-2795, issn 0732-183X, 12 p.Article

American Society of Clinical Oncology Provisional Clinical Opinion : Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody TherapyALLEGROA, Carmen J; MILBURN JESSUP, J; SOMERFIELD, Mark R et al.Journal of clinical oncology. 2009, Vol 27, Num 12, pp 2091-2096, issn 0732-183X, 6 p.Article

Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897AMBROSONE, Christine B; BARLOW, William E; RAVDIN, Peter M et al.Journal of clinical oncology. 2009, Vol 27, Num 30, pp 4973-4979, issn 0732-183X, 7 p.Article

Estrogen Receptor Genotypes Influence Hot Flash Prevalence and Composite Score Before and After Tamoxifen TherapyYAN JIN; HAYES, Daniel F; STORNIOLO, Anna Maria et al.Journal of clinical oncology. 2008, Vol 26, Num 36, pp 5849-5854, issn 0732-183X, 6 p.Article

An academic health center cost analysis of screening mammography: Creating a financially viable serviceCHEN, Steven L; CLARK, Samuel; PIERCE, Lori J et al.Cancer. 2004, Vol 101, Num 5, pp 1043-1050, issn 0008-543X, 8 p.Article

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetineSTEARNS, Vered; JOHNSON, Michael D; RAE, James M et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 23, pp 1758-1764, issn 0027-8874, 7 p.Article

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer : Clinical practice guidelines of the American Society of Clinical OncologyBAST, Robert C; RAVDIN, Peter; HAYES, Daniel F et al.Journal of clinical oncology. 2001, Vol 19, Num 6, pp 1865-1878, issn 0732-183XArticle

Prognostic significance of Plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate Cancer treated on Cancer and leukemia Group B 9480GEORGE, Daniel J; HALABI, Susan; SHEPARD, Timothy F et al.Clinical cancer research. 2001, Vol 7, Num 7, pp 1932-1936, issn 1078-0432Article

Page / 4